Why do we continue to qualify and validate our systems and equipment on paper and what are the issues? How do we move forward to an electronic alternative?
The paper-based validation process has become expensive, time consuming, and labor intensive. It is a bureaucratic process focused on the creation of templates printed on paper, time spent in the collection of evidence, preparing and storage of documentation and folders, and sequential signature collection based on workflow review. As of today, a number of paperless systems have become available on the market with the focus of addressing these issues and providing a platform that automatically and electronically manages the validation lifecycle. This webinar will provide an overview of the paperless validation approach, key issues to be addressed in the selection of a system, provide a case study example an implementation effort currently underway at Novo Nordisk, Sartorius, and Genmab A/S.
Become a member today
Gain the knowledge and competitive edge you need to succeed in the pharmaceutical and biopharmaceutical engineering industries and join more than 18,000 pharma professionals from around the world by becoming an ISPE Member.